Skip to content

OS Therapies OSTX Increase Decrease In Accrued Interest Receivable Net

Increase Decrease In Accrued Interest Receivable Net at other companies

Simmons First National logo
Simmons First NationalSFNC
-$2.51M+57.1%
Quantum Computing Inc. logo
Quantum Computing Inc.QUBT
$1.68M
The Bancorp logo
The BancorpTBBK
-$1.78M-336%
Columbia Financial, Inc. logo
Columbia Financial, Inc.CLBK
$315K-79.3%
RFL
Rafael Holdings, Inc.RFL
-$438K-1,360%
SB Financial Group logo
SB Financial GroupSBFG
$9K-94.5%

Other financials

Income statement

See full
Operating income-$10.2M-103%
Net income-$10.4M-168%
EPS (diluted)-$0.27-50.0%

Balance sheet

See full
Cash & equivalents$917.6K-69.1%
Total debt$20.0M
Total equity-$10.8M-159%
Total assets$7.3M+71.7%

Cash flow

See full
Operating cash flow-$4.6M-32.6%
CapEx$316.4K
Free cash flow-$3.7M

Valuation

See full
Market cap$84.62M+65.5%
Enterprise value$103.7M

Returns & leverage

See full
Return on equity470%
Debt / equity-1.8×
Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's increase decrease in accrued interest receivable net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OS Therapies's increase decrease in accrued interest receivable net?
OS Therapies (OSTX) reported increase decrease in accrued interest receivable net of -$6.37K in Q1 2026.
What does increase decrease in accrued interest receivable net mean?
Tracks the net change in interest income that has been earned on financial assets but not yet collected in cash. It is a key indicator of the yield generated from the company's cash and investment holdings.